Assessment of Serum Biomarkers associated with Vedolizumab Therapy Response in Inflammatory Bowel Disease.

被引：0
|
作者：
O'Connell, J. [1 ]
Argue, R. [1 ]
Dunne, M. [2 ]
O'Connell, F. [2 ]
Breslin, N. [3 ]
Cullen, G. [4 ]
Doherty, G. [4 ]
Dunne, C. [1 ]
Hartery, K. [1 ]
Ismail, M. S. [3 ]
MacCarthy, F. [1 ]
McDonagh, P. [1 ]
McKiernan, S. [1 ]
McNamara, D. [3 ]
Mulcahy, H. [1 ,4 ]
O'Connor, A. [3 ]
Ryan, B. [3 ]
Sheridan, J. [4 ]
O'Sullivan, J. [2 ]
Kevans, D. [1 ]
机构：
[1] St James Hosp, Gastroenterol, Dublin, Ireland
[2] Trinity Coll Dublin, Trinity Translat Med Inst, Surg, Dublin, Ireland
[3] Tallaght Univ Hosp, Gastroenterol, Dublin, Ireland
[4] St Vincents Univ Hosp, Gastroenterol, Dublin, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P041
引用
收藏
页码：I299 / I299
页数：1
相关论文
共 50 条
  • [31] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
  • [32] Novel biomarkers associated with inflammatory bowel disease
    Baldan-Martin, M.
    Lloro, I.
    Azkargorta, M.
    Orejudo, M.
    Ramirez, C.
    Soleto, I.
    Mercado, J.
    Suarez-Trujillo, F.
    Sanchez-Sanchez, C.
    Gordillo-Velez, C. H.
    Riestra, S.
    Rivero, M.
    Gutierrez, A.
    Rodriguez-Lago, I.
    Fernandez-Salazar, L.
    Ceballos, D.
    Benitez, J. M.
    Aguas, M.
    Rey, I. Baston
    Bermejo, F.
    Casanova, M. J.
    Lorente, R.
    Ber, Y.
    Royo, V.
    Esteve, M.
    Elortza, F.
    Gisbert, J. P.
    Chaparro, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I483 - I484
  • [33] Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
    Gabriels, Ruben Y.
    Bourgonje, Arno R.
    von Martels, Julius Z. H.
    Blokzijl, Tjasso
    Weersma, Rinse K.
    Galinsky, Kevin
    Juarez, Julius
    Faber, Klaas Nico
    Kats-Ugurlu, Gursah
    Dijkstra, Gerard
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [34] VEDOLIZUMAB DRUG LEVELS ARE NOT ASSOCIATED WITH OUTCOMES OR DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE
    Shields, Stephanie
    Seenan, John Paul
    Nowell, Emma
    Dunlop, Allan
    Galloway, Peter
    Macdonald, Jonathan
    GUT, 2021, 70 : A122 - A123
  • [35] The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease
    Kamal, Natasha
    Marciano, Beatriz
    Curtin, Bryan
    Strongin, Anna
    DeRavin, Suk See
    Bousvaros, Athos
    Koh, Christopher
    Malech, Harry L.
    Holland, Steven M.
    Zerbe, Christa
    Heller, Theo
    GASTROENTEROLOGY REPORT, 2020, 8 (05): : 404 - 406
  • [36] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [37] SURGICAL OUTCOMES OF PATIENTS TREATED WITH USTEKINUMAB VS. VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE.
    Novello, M.
    Holubar, S.
    Shawki, S.
    Lipman, J.
    Gorgun, E.
    Hull, T.
    Steele, S. R.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E132 - E133
  • [38] Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease"
    Pauwels, Renske W. M.
    de Vries, Annemarie C.
    van der Woude, C. Janneke
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (05) : E59 - E59
  • [39] Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
    Barre, A.
    Colombel, J. -F.
    Ungaro, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 896 - 905
  • [40] Radiation therapy in patients with inflammatory bowel disease. A review
    Jmour, Omar
    Pellat, Anna
    Colson-Durand, Laurianne
    Nhu Hanh To
    Latorzeff, Igor
    Sargos, Paul
    Sobhani, Iradj
    Belkacemi, Yazid
    BULLETIN DU CANCER, 2018, 105 (05) : 517 - 522
12345